| Overview |
| bs-15203R-PE |
| C5orf35 Polyclonal Antibody, PE Conjugated |
| WB |
| Human, Dog |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human C5orf35 |
| 1-100/299 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 133383 |
| Nucleus |
| C5orf35 chromosome 5 open reading frame 35; Chromosome 5 open reading frame 35; Hypothetical protein LOC133383; MGC33648; Uncharacterized protein C5orf35; SET domain-containing protein 9; SETD9_HUMAN. |
| C5orf35 is a With 181 million base pairs encoding around 1,000 genes, chromosome 5 is about 6% of human genomic DNA. It is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous polyposis through the adenomatous polyposis coli (APC) tumor suppressor gene. Treacher Collins syndrome is also chromosome 5 associated and is caused by insertions or deletions within the TCOF1 gene. Deletion of the p arm of chromosome 5 leads to Cri du chat syndrome. Deletion of 5q or chromosome 5 altogether is common in therapy-related acute myelogenous leukemias and myelodysplastic syndrome. The C5orf35 gene product has been provisionally designated C5orf35 pending further characterization. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz